Rwanda
Tuberculosis profile
| High HIV burden |
Population  2012 11 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 1.2 (0.53–2.1) 10 (4.6–18)
Mortality (HIV+TB only) 0.74 (0.6–0.92) 6.5 (5.2–8)
Prevalence  (includes HIV+TB) 13 (7–21) 114 (61–183)
Incidence  (includes HIV+TB) 9.8 (8.8–11) 86 (77–96)
Incidence (HIV+TB only) 2.9 (2.6–3.2) 25 (22–28)
Case detection, all forms (%) 62 (56–69)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 3 571 (61) Relapse 212 (64)
Smear-negative 617 (10) Treatment after failure 90 (27)
Smear-unknown / not done 241 (4) Treatment after default 27 (8)
Extrapulmonary 1 247 (21) Other 0 (0)
Other 203 (3)      
Total new 5 879   Total retreatment 329  
           
Other (history unknown) 0        
Total new and relapse 6 091   Total cases notified 6 208  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.0    
Age < 15 62 192 140
Laboratories 2012
Smear (per 100 000 population) 1.7
Culture (per 5 million population) 0.9
Drug susceptibility testing (per 5 million population) 0.9
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 89   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 75  
Retreatment 80  
TB/HIV 2012 Number (%)
TB patients with known HIV status 6 131 (99)
HIV-positive TB patients 1 601 (26)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 1 586 (99)
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB 121 810  
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 3.9 (2.5–5.8) 19 (15–23)
MDR-TB cases among notified pulmonary
TB cases
180 (120–270) 63 (51–76)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB     1 072
Laboratory-confirmed MDR-TB cases     58
Patients started on MDR-TB treatment     58
Financing TB control 2013
National TB programme budget (US$ millions)  
% Funded domestically  
% Funded internationally  
% Unfunded  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-25 Data: www.who.int/tb/data